| Literature DB >> 22708803 |
Jon L Hobman1, Daniel J Julian, Nigel L Brown.
Abstract
BACKGROUND: The pbr resistance operon from Cupriavidus metallidurans CH34 plasmid pMOL30 confers resistance to Pb(II) salts, and is regulated by the Pb(II) responsive regulator PbrR, which is a MerR family activator. In other metal sensing MerR family regulators, such as MerR, CueR, and ZntR the cognate regulator binds to a promoter with an unusually long spacer between the -35 and -10 sequences, and activates transcription of resistance genes as a consequence of binding the appropriate metal. Cysteine residues in these regulators are essential for metal ion coordination and activation of expression from their cognate promoter. In this study we investigated the interaction of PbrR with the promoter for the structural pbr resistance genes, PpbrA, effects on transcriptional activation of altering the DNA sequence of PpbrA, and effects on Pb(II)-induced activation of PpbrA when cysteine residues in PbrR were mutated to serine.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22708803 PMCID: PMC3431237 DOI: 10.1186/1471-2180-12-109
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Bacterial strains and plasmids
| | | |
| TG2 | [ | |
| BL21(DE3)pLysS | F- | Novagen |
| | | |
| CH34 | Zn, Cd, Co, Pb, Cu, Hg, Ni and Cr resistance | [ |
| AE104 | Plasmid-cured | [ |
| Plasmid | Description | Reference or source |
| pET32LIC | Apr Overexpression plasmid for ligation-independent cloning | Novagen |
| pET32LIC | Apr | This study |
| pMa5/8 | Apr Cms Mutagenesis vector | [ |
| pMc5/8 | Aps Cmr Mutagenesis vector | [ |
| pMaPbrR/P | Apr Cms Mutagenesis vector with | This study |
| pMOL1139 | Kmr, The | B. Borremans |
| pMU2385 | Tpr 13.3 kb low copy number | [ |
| pMUP | Tpr pMU2385 containing the PpbrA promoter directing | This study |
| pMUP | Tpr pMU2385 containing the PpbrA promoter with a 1 bp deletion | This study |
| pMUP | Tpr As pMU | This study |
| pMUP | Tpr As pMU | This study |
| pMUPbrR/P | Tpr, pMU2385 containing | This study |
| pMUPbrRC14S/P | As pMUPbrRP | This study |
| pMUPbrRC55S/P | As pMUPbrRP | This study |
| pMUPbrRC79S/P | As pMUPbrRP | This study |
| pMUPbrRC114S/P | As pMUPbrRP | This study |
| pMUPbrRC132S/P | As pMUPbrRP | This study |
| pMUPbrRC134S/P | As pMUPbrRP | This study |
| pMUPbrRC132,134 S/P | As pMUPbrRP | This study |
| pUC21 | Apr, high copy number cloning vector; ColE1 replicon | [ |
| pUK21 | Kmr, intermediate copy number cloning vector; p15A replicon | [ |
| pUK21 | Kmr, | This study |
Oligonucleotides used for site directed mutagenesis, and overexpression
| 5’ CCA CCG GG | PbrR mutagenesis primer | |
| 5’ CCA GAG ACC GG | PbrR mutagenesis primer | |
| 5’ GAC TTC ACC G | PbrR mutagenesis primer | |
| 5’ GGC ACC AGA A | PbrR mutagenesis primer | |
| 5’ GCA GAA TCC CG | PbrR mutagenesis primer | |
| 5’ CGT ATC ACA CAC G | PbrR mutagenesis primer | |
| 5’ CGT ATC A | PbrR mutagenesis primer | |
| 5’ CGT ATC A | PbrR mutagenesis primer | |
| 5’ GCG CCA ACC GTG CTC GGT TCT GGG 3’ | Primer extension/sequencing primer [ | |
| pbrBstEII | 5’ GCG AAT GGT CAC CAC CGG 3’ | Primer to amplify |
| pbrNruI | 5’ GCT TGT CGC GAA TCA GCG 3’ | Primer to amplify |
| pMU forward | 5’ GAT TCT CCC CAC ATC ACC AG 3’ | Sequencing primer for pMU2385 |
| pMU reverse | 5’ TGC CAG CAT TTC ATA ACC AA 3’ | Sequencing primer for pMU2385 |
| M13-F | 5’ CGC CAG GGT TTT CCC AGT CAC GAC 3’ | Sequencing primer for pUK plasmids |
| M13-R | 5’ GAG CGG ATA ACA ATT TCA CAC AGG 3’ | Sequencing primer for pUK plasmids |
| con | 5’ CTAGAGGGTTAATCGGCAAC 3’ | P |
| mer | 5’ CTAGAGGGTGTAAGGTCGGCAAC 3’ | P |
| -1EcoPbr | 5’ GGG GAA TTC GAA GCT TGC T 3’ (3’ primer) | P |
| -1CentreBam | 5’ GCC GAT TTA AAC CCT CTA GT 3’ (primer B) | P |
| -1CentreEco | 5’ CGG CTA AAT TTG GGA GAT CA 3’ (primer A) | P |
| -1BamPbr | 5’ CAG TAT ACC TAG GCA GCT GG 3’ (5’ primer) | P |
| 5’ GAC GAC GAC AAG ATG AAT ATC CAG ATC GGC GAG C 3’ | PbrR cloning and overexpression primer | |
| 5’ GAG GAG AAG CCC GGT CTA GTC GCT TGG ATG GGC 3’ | PbrR cloning and overexpression primer | |
| T7 terminator | 5’ CGA TCA ATA ACG AGT CGC C 3’ | Sequencing primer |
Underlined bases highlight alteration from the wild-type sequence.
Figure 1 (a) Gel retardation of Pwith PbrR. Each reaction contained the same amount of 32P-end-labelled 296 bp PpbrA PCR product (60 fmol). Lanes 1, 9 and 10 contained no PbrR. PbrR concentrations in lanes 2–8 and 11–17 increase 2-fold from 0.3 to 19.2 pmol. Lanes 10–17 contained 10 μM Pb(II). (b) DNase I protection assay of PbrR bound to the 296 bp PCR product containing the PbrA promoter. Lanes AGCT, DNA sequence of the 296 bp PCR product pbrA promoter, using the pbrApe primer. Lanes 1 and 4, no added pbrR, lane 2 and 3 increasing amounts of added PbrR. (c) Diagram of the PpbrA promoter. The transcript start site is marked in bold and indicated with an arrow [4]. The region of the promoter protected by PbrR from DNAase I digestion is marked with a box. The predicted −35 and −10 sequences are marked in bold, and the dyad symmetrical sequence is marked with arrows.
Figure 2 Alignment of selected promoters for structural genes regulated by MerR family metal responsive regulators: PbrR[4]; MerR[10], ZntR[23], CueR[20]. The −35 and −10 sequences are marked in BOLD. Arrows show dyad symmetrical DNA sequences within the promoters.
Figure 3 (A) β-galactosidase assay measurement of the activation of P, containing a 1 nt deletion in the 19 bp promoter spacer, to increasing levels of Pb(II) inAE104 carrying pMUPbrR-1. Micromolar Pb(II) concentrations are indicated by the suffix to Pb on the abscissa. Pb0 contains no added Pb(II), Pb200 contains 200 μM Pb(II) . The sequence of wild-type PpbrA and the −1 mutant PpbrA are shown below the graph. The −35 and −10 sequences are marked in BOLD. Arrows show dyad symmetrical DNA sequences within the promoters. (B) β-galactosidase assay measurement of the activation of −10 sequence mutant PpbrA clones in pMU2385 in response to no added Pb(II) or 100 μM Pb(II). WT denotes wild-type −10 sequence (TTAAAT), CON denotes the E. coli consensus promoter −10 sequence (TATAAT) and MER the Tn501 PmerT promoter −10 sequence (TAAGGT). The sequences of the wild-type (PpbrA wt), consensus (PpbrA con), and PmerT-like promoters (PpbrA mer) are shown below the graph. The −35 and −10 sequences are marked in BOLD. Arrows show dyad symmetrical DNA sequences within the promoters, and altered bases are marked in Gray.
Figure 4 β-galactosidase assays inAE104 of Pactivation in response to 20 μM Pb(II) on wild-type PbrR and its cysteine mutants in pMUPbrR/P
Figure 5 ClustalW[47,48]alignment of metal sensing MerR regulators. PbrR (Rmet_5946), PbrR691 (Rmet_2302) and PbrR710 (Rmet_3456) are from the genome of C. metallidurans CH34. CadR is from Pseudomonas stutzeri A1501. ZntR, and CueR are from the E. coli K-12 genome, and MerR is from Tn501. The helices of the Helix-Turn-Helix DNA binding domain are boxed. Essential cysteine residues (Cys14, Cys79, and Cys134 –PbrR numbering) required for activation of PpbrA by PbrR are marked. Key to symbols: * = residues in that column are identical in all sequences in the alignment. The symbol : = conserved substitutions have been observed, and the symbol . = semi-conserved substitutions are observed.